Ironwood Pharmaceuticals (IRWD) Finished Goods (2017 - 2019)

Ironwood Pharmaceuticals (IRWD) has 3 years of Finished Goods data on file, last reported at $191000.0 in Q4 2019.

• For the quarter ending Q4 2019, Finished Goods changed N/A year-over-year to $191000.0; the trailing twelve-month figure through Dec 2019 stood at $191000.0 (changed N/A YoY), and the FY2019 full-year result was $191000.0, changed N/A from the prior year.
• Finished Goods eased to $191000.0 in Q4 2019, from $457000.0 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $1.4 million in Q1 2018 to a low of $76000.0 in Q3 2018.
• A 3-year average of $589428.6 and a median of $479000.0 in 2017 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods plunged 84.13% in 2018 and soared 501.32% in 2019, its largest moves.
• Tracing IRWD's Finished Goods over 3 years: stood at $735000.0 in 2017, then sank by 89.66% to $76000.0 in 2018, then soared by 151.32% to $191000.0 in 2019.
• Business Quant data shows IRWD's Finished Goods at $191000.0 in Q4 2019, $457000.0 in Q3 2019, and $76000.0 in Q3 2018.